Clinical Trials Directory

Trials / Completed

CompletedNCT04273672

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
58 (actual)
Sponsor
University of Massachusetts, Worcester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCognitive BatteryParticipants will be asked to complete a series of cognitive testing (testing of concentration, memory, and other thinking abilities).
BEHAVIORALVoice, Speech and Language AnalysisParticipants will be asked to perform speaking and reading tasks, which will be recorded. Participants will be asked to complete a laptop-based test of language comprehension.
BEHAVIORALQuestionnaires and Clinical AssessmentsParticipants with Parkinson's disease will complete an examination of their symptoms and questionnaires assessing disease symptoms, mood and activities of daily living. Healthy controls participants will be asked to complete questionnaires on mood.
GENETICDNA AnalysisParticipants will have their blood drawn for DNA analysis.

Timeline

Start date
2020-01-13
Primary completion
2023-09-01
Completion
2025-02-28
First posted
2020-02-18
Last updated
2025-06-10
Results posted
2025-06-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04273672. Inclusion in this directory is not an endorsement.